scholarly journals Multiple pulmonary metastases with halo‑sign from malignant mixed M?llerian tumors

2017 ◽  
Author(s):  
Hong‑Wei Tian ◽  
Wei‑Bing Yang ◽  
Meng‑Jie Yang ◽  
Jing‑Yuan Liu ◽  
Jian‑Chu Zhang ◽  
...  
Keyword(s):  
Pulmonary Metastases ◽  
Halo Sign

CT halo sign as an imaging marker for response to adoptive cell therapy in metastatic melanoma with pulmonary metastases

2014 ◽  
Vol 24 (6) ◽  
pp. 1251-1256 ◽  
Author(s):  
Shai Shrot ◽  
Jacob Schachter ◽  
Ronnie Shapira-Frommer ◽  
Michal J. Besser ◽  
Sara Apter
Keyword(s):  
Cell Therapy ◽  
Metastatic Melanoma ◽  
Pulmonary Metastases ◽  
Adoptive Cell Therapy ◽  
Halo Sign

scholarly journals CT halo sign in pulmonary metastases from a melanoma

QJM ◽  
2018 ◽  
Vol 112 (2) ◽  
pp. 133-134 ◽  
Author(s):  
S F Alves Júnior ◽  
G Zanetti ◽  
E Marchiori
Keyword(s):  
Pulmonary Metastases ◽  
Halo Sign

MRI Chest Assessment of Tumor Response Post Microwave Ablation of Pulmonary Metastases

2013 ◽  
Vol 185 (S 01) ◽  
Author(s):  
N Nour-Eldin Mohammed ◽  
N Nguib ◽  
S Zangos ◽  
T Lehnert ◽  
T Gruber-Rouh ◽  
...  
Keyword(s):  
Microwave Ablation ◽  
Tumor Response ◽  
Pulmonary Metastases ◽  
Response Post

Radioiodide Treatment of Pulmonary Metastases of Differentiated Thyroid Cancer

1979 ◽  
Vol 18 (02) ◽  
pp. 86-90 ◽  
Author(s):  
V. Zamrazil ◽  
D. Pohunková ◽  
S. Röhling ◽  
J. Němec
Keyword(s):  
Thyroid Cancer ◽  
Bone Metastases ◽  
Differentiated Thyroid Cancer ◽  
Pulmonary Metastases ◽  
Survival Rates ◽  
Younger Patients ◽  
131I Uptake ◽  
Young Subjects ◽  
Radioiodide Therapy ◽  
Diagnosis Of Thyroid Cancer

Pulmonary metastases were found in 123 out of 840 patients with thyroid cancer between 1955-1977. 87 patients with pulmonary metastases of differentiated cancer were studied in detail, including an evaluation of prognostically important factors. In 66 of them, the induction of 131I uptake in metastases was attempted, in half of them successfully. Uptake was achieved more frequently in younger subjects, in papillary cancers and in patients with fine pulmonary metastases on chest films. Survival (not corrected for age) was evaluated 10 and 15 years following the diagnosis of thyroid cancer and was found to be 29,1 % and 12,2%, respectively. Significantly higher survival rates were seen in younger patients, in patients with the fine type of pulmonary metastases, in the absence of bone metastases and, particularly, in patients with induced 131I uptake in metastases. Papillary cancers were found to have higher survival rates in males and in young subjects only, in the whole group the survival rates were independent of either microscopic type or sex. It is believed that biologic behaviour of distant (pulmonary) metastases may be influenced by radioiodide therapy.

Sign in / Sign up

Export Citation Format

Share Document